Mirae Asset Global Investments’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $132K | Buy |
2,394
+340
| +17% | +$18.8K | ﹤0.01% | 1099 |
|
|
2025
Q1 | $100K | Buy |
2,054
+68
| +3% | +$3.32K | ﹤0.01% | 1129 |
|
|
2024
Q4 | $77.4K | Sell |
1,986
-144
| -7% | -$5.61K | ﹤0.01% | 1194 |
|
|
2024
Q3 | $94.9K | Buy |
2,130
+379
| +22% | +$16.9K | ﹤0.01% | 1188 |
|
|
2024
Q2 | $55.8K | Sell |
1,751
-27,807
| -94% | -$886K | ﹤0.01% | 1228 |
|
|
2024
Q1 | $692K | Sell |
29,558
-2,201
| -7% | -$51.5K | ﹤0.01% | 1736 |
|
|
2023
Q4 | $728K | Sell |
31,759
-5,463
| -15% | -$125K | ﹤0.01% | 1786 |
|
|
2023
Q3 | $621K | Buy |
37,222
+1,555
| +4% | +$25.9K | ﹤0.01% | 1778 |
|
|
2023
Q2 | $986K | Buy |
35,667
+8,038
| +29% | +$222K | ﹤0.01% | 1576 |
|
|
2023
Q1 | $635K | Buy |
27,629
+7,752
| +39% | +$178K | ﹤0.01% | 1813 |
|
|
2022
Q4 | $217K | Buy |
19,877
+20
| +0.1% | +$218 | ﹤0.01% | 2275 |
|
|
2022
Q3 | $167K | Buy |
19,857
+5,934
| +43% | +$49.9K | ﹤0.01% | 2395 |
|
|
2022
Q2 | $110K | Buy |
+13,923
| New | +$110K | ﹤0.01% | 2292 |
|